National Pension Service Has $2.01 Million Position in The Clorox Company $CLX

National Pension Service boosted its position in shares of The Clorox Company (NYSE:CLX) by 88.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 16,304 shares of the company’s stock after buying an additional 7,669 shares during the quarter. National Pension Service’s holdings in Clorox were worth $2,010,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Total Investment Management Inc. acquired a new stake in Clorox in the second quarter worth about $25,000. NewSquare Capital LLC boosted its stake in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares during the last quarter. True Wealth Design LLC grew its position in shares of Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after buying an additional 204 shares during the period. Darwin Wealth Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $29,000. Finally, Root Financial Partners LLC bought a new stake in shares of Clorox during the third quarter worth approximately $29,000. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The stock was bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is currently owned by company insiders.

Clorox Price Performance

NYSE CLX opened at $115.11 on Wednesday. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76. The stock has a market cap of $14.04 billion, a price-to-earnings ratio of 18.07, a PEG ratio of 0.56 and a beta of 0.59. The business has a 50 day simple moving average of $105.19 and a 200 day simple moving average of $113.96. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $159.04.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a net margin of 11.68% and a return on equity of 358.39%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm posted $1.55 EPS. The business’s quarterly revenue was down .8% compared to the same quarter last year. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.3%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly beat consensus, suggesting demand was not as weak as feared; top-line was $1.67B vs. street estimates near $1.64–1.66B. MarketBeat: Earnings Summary
• Positive Sentiment: Operating cash flow rose sharply (reported up ~73% YoY) and capex declined, improving near‑term cash generation and flexibility. These cash-flow improvements can comfort investors despite EPS pressure. Quiver Quant: Financials
• Neutral Sentiment: Company confirmed its outlook in the PR release, which reduces uncertainty from the print even if guidance wasn’t materially raised. PR Newswire: Q2 Results & Outlook
• Neutral Sentiment: Management is hosting a conference call and released supplemental materials—investors will listen for management’s detail on cadence to recovery and margin actions. Earnings Materials
• Negative Sentiment: EPS missed estimates (reported $1.39 vs. $1.43 Zacks / ~$1.45 consensus elsewhere) and fell from $1.55 a year ago, signaling margin pressure and/or share‑count effects that hurt per‑share profitability. Zacks: EPS Miss
• Negative Sentiment: Management cited weaker sales volumes driven by shoppers seeking cheaper alternatives and macro headwinds (including the government shutdown), and said higher costs weighed on profits—these are demand and margin risks going forward. Reuters: Muted Demand & Costs
• Negative Sentiment: Analyst sentiment remains mixed/soft (recent median price targets near the current trading level and at least one underweight), which could limit upside until clearer evidence of margin recovery appears. Quiver Quant: Analyst & Hedge Fund Notes

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CLX shares. The Goldman Sachs Group reduced their price objective on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research note on Wednesday, January 7th. Rothschild & Co Redburn reduced their price target on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Citigroup decreased their price objective on Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a research note on Wednesday, December 17th. TD Cowen reissued a “hold” rating on shares of Clorox in a research note on Thursday, January 8th. Finally, Morgan Stanley reduced their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $120.33.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.